Drug Profile
DC-Vac/EP-L injection
Latest Information Update: 28 Oct 2019
Price :
$50
*
At a glance
- Originator Binex
- Class Antineoplastics; Immunotherapies
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Lung cancer
Most Recent Events
- 28 Oct 2019 No recent reports of development identified for clinical-Phase-Unknown development in Lung-cancer in South Korea (Parenteral, Injection)
- 03 Aug 2016 Clinical trials in Lung cancer in South Korea (Parenteral)